Eco Animal Health (GB:EAH) has released an update.
Eco Animal Health reported a 13% drop in revenue to £33.2 million for the first half of 2024, impacted by currency fluctuations and reduced demand in China. However, the company maintains a positive outlook for the second half, buoyed by increased sales in North America and Latin America and strategic investments in its R&D pipeline. ECO also capitalized on the disposal of a non-core product, generating a £1.0 million gain, as it focuses on strengthening its core veterinary offerings.
For further insights into GB:EAH stock, check out TipRanks’ Stock Analysis page.